SCHEMBL7825873

SCHEMBL7825873

Cc1ccc2nc(N)[nH]c(=O)c2c1Br

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TYMS P04818 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7826334 0.83 PARP1 (0.60) TYMS
SCHEMBL27555186 0.81 TYMS (0.58) TYMS
SCHEMBL22233998 0.74 TYMS (0.56) TYMS
SCHEMBL6651315 0.74 TYMS (1.00) TYMS
SCHEMBL14080068 0.73 TYMS (0.70) TYMS
SCHEMBL6650317 0.73 TYMS (1.00) TYMS
SCHEMBL6649537 0.73 TYMS (1.00) TYMS
SCHEMBL6653074 0.72 TYMS (1.00) TYMS
SCHEMBL6652802 0.72 TYMS (1.00) TYMS
SCHEMBL6455624 0.72 TYMS (1.00) TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1335307-A Synthesis process of 2-amino quinbolone compounds MILITARY MEDICAL UNIV NO 1 PLA (CN) 2002-02-13 CN disclosed
EP-0637300-B1 ANTIPROLIFERATIVE QUINAZOLINES AGOURON PHARMA (US) 2001-09-05 EP disclosed
EP-0637300-A1 ANTIPROLIFERATIVE QUINAZOLINES AGOURON PHARMACEUTICALS, INC. (US) 1995-02-08 EP disclosed
WO-1993020055-A1 ANTIPROLIFERATIVE QUINAZOLINES AGOURON PHARMACEUTICALS, INC. (US) 1993-10-14 WO disclosed